Bayer Aktiengesellschaft (BAYER.BD)

Compare

9,517.00

+339.00

+(3.69%)

As of 9:59:40 AM GMT+1. Market Open.

Exclusive-Bayer share drop draws market regulator's scrutiny, source says

FRANKFURT (Reuters) -Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get shareholder approval for a potential capital increase, a regulatory source told Reuters on Tuesday. Under the "routine" investigation that was triggered by the strong decline in Bayer's share price last Friday, watchdog BaFin is checking whether there are grounds for a wider investigation, the person familiar with the matter told Reuters. The healthcare and agriculture group said in a statement on Friday it would seek shareholder approval to potentially increase shares outstanding by close to 35% over the next three years to cover possible costs of U.S. litigation.

Reuters 5 days ago

BAYN.DE
Multiple authorities investigate alleged arson attack on Bayer executive's NJ home

A Bayer executive's house was targeted by an alleged arsonist in New Jersey this week.

Yahoo Finance 9 days ago

BAYRY

BAYZF
Bayer told analysts of cash call plan a day before official statement

FRANKFURT (Reuters) -Bayer told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, which weighed heavily on the stock, analysts' notes seen by Reuters showed. The healthcare and agriculture group said in a statement on Friday it would seek shareholder approval at its annual meeting on April 25 potentially to increase shares outstanding by about 35% over the next three years to cover possible costs of U.S. litigation. In a note dated Thursday and seen by Reuters, Jefferies analysts told clients about Bayer's plan, citing detailed remarks by Bayer's leadership to a meeting that day of sell-side analysts from several brokerages.

Reuters 9 days ago

BAYN.DE
Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?

Here is how Bayer Aktiengesellschaft (BAYRY) and AbbVie (ABBV) have performed compared to their sector so far this year.

Zacks 9 days ago

BAYN.DE

ABBV
Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More

Bayer announces fourth-quarter results. NVO cuts cost of Wegovy for the uninsured. ABBV enters obesity space with new deal.

Zacks 9 days ago

ABBV

BAYN.DE

NVO
Bayer Weighs Billions in Capital Raise, Sending Shares Tumbling

(Bloomberg) -- Bayer AG is seeking shareholder authorization to raise billions of euros through a capital increase in case it needs to quickly resolve its US legal troubles, causing the stock price to plummet.Most Read from BloombergTrump Administration Plans to Eliminate Dozens of Housing OfficesNJ College to Merge With State School After Financial StressRepublican Mayor Braces for Tariffs: ‘We Didn’t Budget for This’How Upzoning in Cambridge Broke the YIMBY MoldNYC’s Finances Are Sinking With

Bloomberg 10 days ago

BAYN.DE
Bayer tells US it could halt Roundup weedkiller sales over legal risks

FRANKFURT (Reuters) -Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability litigation, according to a financial analyst and a person close to the matter. Bayer has paid about $10 billion to settle disputed claims that Roundup, based on the herbicide glyphosate, causes cancer. The German company has said plaintiffs should not be able to take Bayer to court by invoking U.S. state rules given the federal U.S. Environmental Protection Agency has repeatedly labelled the product as safe to use, as have regulators in other parts of the world.

Reuters 10 days ago

BAYN.DE
Bayer Full Year 2024 Earnings: EPS Misses Expectations

Bayer ( ETR:BAYN ) Full Year 2024 Results Key Financial Results Revenue: €46.6b (down 2.2% from FY 2023). Net loss...

Simply Wall St. 10 days ago

BAYRY

BAYZF
Why Is Regeneron (REGN) Down 4.1% Since Last Earnings Report?

Regeneron (REGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 10 days ago

REGN

SNY

BAYN.DE
Bayer AG (BAYRY) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges

Bayer AG (BAYRY) reports modest sales growth and debt reduction amid financial headwinds and strategic challenges.

GuruFocus.com 11 days ago

BAYN.DE
Bayer Q4 Earnings In Line, Revenues Top on Nubeqa, Kerendia Sales

BAYRY's fourth-quarter earnings match expectations. Revenues top estimates, driven by the strong performance of its pharmaceutical business.

Zacks 11 days ago

BAYN.DE
Bayer braces for ‘difficult’ year before turnaround pays dividends

CEO Bill Anderson warned investors that profits will decline in 2025 before the company’s ongoing shake-up leads to an “improved trajectory” next year.

BioPharma Dive 12 days ago

BAYN.DE
Bayer Warns of Lower Earnings as Turnaround Continues

Bayer guided for lower earnings this year as it continues to work through a turnaround plan, but said performance is expected to improve from 2026.

The Wall Street Journal 12 days ago

BAYRY

BAYZF
Bayer faces investors' impatience ahead of fourth-quarter results

FRANKFURT (Reuters) -Bayer's CEO is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline this year, as the group prepares to release quarterly results on Wednesday. CEO Bill Anderson is in the middle of cutting managerial jobs, speeding up decision-making and slashing red tape, and has put on hold plans to break up Bayer diversified businesses. But investors are questioning whether he is doing enough amid a plethora of problems that have dragged shares lower.

Reuters 12 days ago

BAYN.DE
Stocks to watch this week: Broadcom, Costco, JD.com, Adidas and Greggs

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 16 days ago

APAX.L

LCSHF

LCSHY
Bayer CEO Bill Anderson’s war against bureaucracy

Also: Tesla shares fall as Q1 worries accrue, Jamie Dimon apologizes for cursing, not for DEI.

Fortune 19 days ago

BAYN.DE
BridgeBio price target raised to $49 from $48 at Scotiabank

Scotiabank analyst Greg Harrison raised the firm’s price target on BridgeBio (BBIO) to $49 from $48 and keeps an Outperform rating on the shares. BridgeBio recently announced its European partner Bayer (BAYRY) was granted a marketing authorization for transthyretin stabilizer acoramidis by the European Commission, which will treat adults with wild-type or variant transthyretin amyloidosis with cardiomyopathy, the analyst tells investors. The firm anticipates the EU launch of acoramidis in 1H25 w

TipRanks last month

BAYRY

BAYZF

BBIO
Regeneron Beats on Q4 Earnings, Initiates Quarterly Dividend

REGN reports better-than-expected Q4 results. However, lead drug Eylea sales decline in the United States due to competition. The company initiates a dividend program,

Zacks last month

REGN

SNY

BAYN.DE
Dhanuka Agritech Ltd (BOM:507717) Q3 FY25 Earnings Call Highlights: Strong Revenue and Profit ...

Dhanuka Agritech Ltd (BOM:507717) reports impressive financial growth with strategic expansions, despite facing inventory and market challenges.

GuruFocus.com last month

BAYN.DE
Agtech Seedlings: CH4 Global to expand methane-reducing cattle feed with Mitsubishi

Also in this week’s farm technology news: Deere & Co. will partner with six agtech startups in 2025, and Google makes two biochar carbon credit deals.

Agriculture Dive last month

DE

BAYRY

Performance Overview

Return	BAYER.BD	DAX P
YTD	+19.92%	+15.87%
1-Year	-9.21%	+28.61%
3-Year	-57.47%	+60.33%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bayer Aktiengesellschaft (BAYER.BD)

Exclusive-Bayer share drop draws market regulator's scrutiny, source says

Multiple authorities investigate alleged arson attack on Bayer executive's NJ home

Bayer told analysts of cash call plan a day before official statement

Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?

Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More

Bayer Weighs Billions in Capital Raise, Sending Shares Tumbling

Bayer tells US it could halt Roundup weedkiller sales over legal risks

Bayer Full Year 2024 Earnings: EPS Misses Expectations

Why Is Regeneron (REGN) Down 4.1% Since Last Earnings Report?

Bayer AG (BAYRY) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges

Bayer Q4 Earnings In Line, Revenues Top on Nubeqa, Kerendia Sales

Bayer braces for ‘difficult’ year before turnaround pays dividends

Bayer Warns of Lower Earnings as Turnaround Continues

Bayer faces investors' impatience ahead of fourth-quarter results

Stocks to watch this week: Broadcom, Costco, JD.com, Adidas and Greggs

Bayer CEO Bill Anderson’s war against bureaucracy

BridgeBio price target raised to $49 from $48 at Scotiabank

Regeneron Beats on Q4 Earnings, Initiates Quarterly Dividend

Dhanuka Agritech Ltd (BOM:507717) Q3 FY25 Earnings Call Highlights: Strong Revenue and Profit ...

Agtech Seedlings: CH4 Global to expand methane-reducing cattle feed with Mitsubishi

Performance Overview